Comparative Study of NXL103 Versus Comparator in Adults With Community Acquired Pneumonia
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy, safety and tolerance of 2 different
dose levels of oral NXL103 with oral comparator in the treatment of community acquired
pneumonia in adults